MedTrace Logo

Clinical Features of COVID-19 Patients

NCT04815304 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 200

Last updated 2023-11-27

No results posted yet for this study

Summary

The data were retrospectively collected during the first and the second wave of epidemic in COVID-19 patients with Severe Acute Respiratory Syndrome Coronavirus 2, at the moment of intensive care unit admission and during the in intensive care unit staying.

Conditions

  • Covid19
  • Acute Respiratory Distress Syndrome
  • Ventilatory Failure

Interventions

DIAGNOSTIC_TEST

peripheral lymphocytes subsets

The data were collected during the first and the second wave of epidemic in COVID-19 patients with acute respiratory distress syndrome. At the moment of hospitalization, at the moment of intensive care unit admission and during the in intensive care unit staying, the following data were collected: peripheral lymphocyte subsets were measured by multiple-color flow cytometry, chest computed tomography and ultrasonography scans (lung ultrasound score, diaphragmatic thickness and motion), arterial blood gas analysis parameters (pH, partial pressure of carbon dioxide, partial pressure of oxygen, concentration of hydrogen carbonate, base excess, and arterial oxygen saturation ), and pain assessed by using numeric rating scale. Macroscopic and microscopic hypopharynx and larynx damages were also evaluated by video-laryngoscopy and light miscoscopy.

Sponsors & Collaborators

  • San Salvatore Hospital of L'Aquila

    lead OTHER

Principal Investigators

  • Franco Marinangeli, MD · ASL 1 Avezzano Sulmona L'Aquila

Eligibility

Min Age
18 Years
Max Age
90 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2020-03-13
Primary Completion
2023-10-28
Completion
2023-11-13

Countries

  • Italy

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04815304 on ClinicalTrials.gov